Immunoscore As A Parameter Predicting Time To Recurrence And Disease-Free Survival In T4n0 Stage Ii Colon Cancer Patients.

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 4|浏览48

暂无评分

摘要

4105Background: Risk assessment is particularly important to decide when to propose an adjuvant treatment for Stage II Colon Cancer (CC) patients. However, the current tumor risk features are imper...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要